When to Start Treatment? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data

被引:160
作者
Cain, Lauren E. [1 ]
Robins, James M. [1 ]
Lanoy, Emilie [2 ]
Logan, Roger [1 ]
Costagliola, Dominique [2 ,3 ]
Hernan, Miguel A. [1 ,4 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[2] INSERM, U943, Paris, France
[3] Univ Paris 06, Paris, France
[4] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA
关键词
dynamic treatment regimes; marginal structural models; HIV infection; antiretroviral therapy; MARGINAL STRUCTURAL MODELS; ANTIRETROVIRAL THERAPY; CONTROLLED-TRIAL; ZIDOVUDINE; DEATH; AIDS;
D O I
10.2202/1557-4679.1212
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Dynamic treatment regimes are the type of regime most commonly used in clinical practice. For example, physicians may initiate combined antiretroviral therapy the first time an individual's recorded CD4 cell count drops below either 500 cells/mm(3) or 350 cells/mm(3). This paper describes an approach for using observational data to emulate randomized clinical trials that compare dynamic regimes of the form "initiate treatment within a certain time period of some time-varying covariate first crossing a particular threshold." We applied this method to data from the French Hospital database on HIV (FHDH-ANRS CO4), an observational study of HIV-infected patients, in order to compare dynamic regimes of the form "initiate treatment within m months after the recorded CD4 cell count first drops below x cells/mm(3)" where x takes values from 200 to 500 in increments of 10 and m takes values 0 or 3. We describe the method in the context of this example and discuss some complications that arise in emulating a randomized experiment using observational data.
引用
收藏
页数:25
相关论文
共 28 条
  • [1] EXPANDED EUROPEAN AIDS CASE DEFINITION
    ANCELLEPARK, R
    [J]. LANCET, 1993, 341 (8842) : 441 - 441
  • [2] [Anonymous], 1993, MMWR Recomm Rep, V1992, P1
  • [3] Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
    Cameron, DW
    Heath-Chiozzi, M
    Danner, S
    Cohen, C
    Kravcik, S
    Maurath, C
    Sun, E
    Henry, D
    Rode, R
    Potthoff, A
    Leonard, J
    [J]. LANCET, 1998, 351 (9102) : 543 - 549
  • [4] Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models
    Cole, SR
    Hernán, MA
    Robins, JM
    Anastos, K
    Chmiel, J
    Detels, R
    Ervin, C
    Feldman, J
    Greenblatt, R
    Kingsley, L
    Lai, SH
    Young, M
    Cohen, M
    Muñoz, A
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (07) : 687 - 694
  • [5] Accounting for leadtime in cohort studies:: evaluating when to initiate HIV therapies
    Cole, SR
    Li, R
    Anastos, K
    Deteis, R
    Young, M
    Chmiel, JS
    Muñoz, A
    [J]. STATISTICS IN MEDICINE, 2004, 23 (21) : 3351 - 3363
  • [6] Constructing inverse probability weights for marginal structural models
    Cole, Stephen R.
    Hernan, Miguel A.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 168 (06) : 656 - 664
  • [7] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
    Hammer, SM
    Squires, KE
    Hughes, MD
    Grimes, JM
    Demeter, LM
    Currier, JS
    Eron, JJ
    Feinberg, JE
    Balfour, HH
    Dayton, LR
    Chodakewitz, JA
    Fischl, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 725 - 733
  • [8] Does obesity shorten life?: The importance of well-defined interventions to answer causal questions
    Hernan, M. A.
    Taubman, S. L.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (Suppl 3) : S8 - S14
  • [9] Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
    Hernán, MA
    Brumback, B
    Robins, JM
    [J]. EPIDEMIOLOGY, 2000, 11 (05) : 561 - 570
  • [10] Comparison of dynamic treatment regimes via inverse probability weighting
    Hernán, MA
    Lanoy, E
    Costagliola, D
    Robins, JM
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (03) : 237 - 242